This file is part of IDEAS , which uses RePEc data
[ Papers |
Articles |
Software |
Books |
Chapters |
Authors |
Institutions |
JEL Classification |
NEP reports |
Search |
New papers by email |
Author registration |
Rankings |
Volunteers |
FAQ |
Blog |
Help! ]
Research classified by
Journal of
Economic Literature (JEL) codes Top JEL D: Microeconomics D0 : GeneralD1 : Household BehaviorD2 : Production and OrganizationsD3 : DistributionD4 : Market Structure and PricingD5 : General Equilibrium and DisequilibriumD6 : Welfare EconomicsD7 : Analysis of Collective Decision-MakingD8 : Information, Knowledge, and UncertaintyD9 : Intertemporal Choice and Growth2008 The impact of ballot access restrictions on electoral competition: Evidence from a natural experiment by Drometer, Marcus & Rincke, Johannes [Downloadable!] 2008 The impact of ballot access restrictions on electoral competition: Evidence from a natural experiment by Drometer, Marcus & Rincke, Johannes [Downloadable!] 2008 The strategies of multilatinas: from the quest for regional leadership to the myth of the global corporation \r\n by Alexandre MINDA (LEREPS-GRES) [Downloadable!] 2008 Foolishness and Identity: Amartya Sen and Adam Smith by Caroline Gerschlager [Downloadable!] 2008 Foolishness and Identity: Amartya Sen and Adam Smith by Caroline Gerschlager [Downloadable!] 2008 Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study by Martin Knapp & Frank Windmeijer & Jacqueline Brown & Stathis Kontodimas & Spyridon Tzivelekis & Josep Maria Haro & Mark Ratcliffe & Jihyung Hong & Diego Novick [Downloadable!] 2008 An Economic Evaluation of Atorvastatin for Primary Prevention of Cardiovascular Events in Type 2 Diabetes by Scott D. Ramsey & Lauren D. Clarke & Craig S. Roberts & Sean D. Sullivan & Scott J. Johnson & Larry Z. Liu [Downloadable!] 2008 Cost Effectiveness of Ibandronate for the Prevention of Fractures in Inflammatory Bowel Disease-Related Osteoporosis: Cost-Utility Analysis Using a Markov Model by Simon Kreck & Jochen Klaus & Reiner Leidl & Christian von Tirpitz & Alexander Konnopka & Herbert Matschinger & Hans-Helmut Konig [Downloadable!] 2008 The Use of QALY Weights for QALY Calculations: A Review of Industry Submissions Requesting Listing on the Australian Pharmaceutical Benefits Scheme 2002-4 by Paul A. Scuffham & Jennifer A. Whitty & Andrew Mitchell & Rosalie Viney [Downloadable!] 2008 Making a Case for Employing a Societal Perspective in the Evaluation of Medicaid Prescription Drug Interventions by Sanjoy Roy & S. Suresh Madhavan [Downloadable!] 2008 An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare by Marc A. Koopmanschap & N. Job A. van Exel & Bernard van den Berg & Werner B.F. Brouwer [Downloadable!] 2008 Zoledronic Acid: A Pharmacoeconomic Review of its Use in the Management of Bone Metastases by Kate McKeage & Greg L. Plosker [Downloadable!] 2008 Community and Patient Values for Preventing Herpes Zoster by Tracy A. Lieu & Ismael Ortega-Sanchez & G. Thomas Ray & Donna Rusinak & W. Katherine Yih & Peter W. Choo & Irene Shui & Ken Kleinman & Rafael Harpaz & Lisa A. Prosser [Downloadable!] 2008 Preferences of Patients with Diabetes Mellitus for Inhaled versus Injectable Insulin Regimens by Jeremy Chancellor & Samuel Aballea & Alison Lawrence & Rob Sheldon & Sandrine Cure & Juliette Plun-Favreau & Nick Marchant [Downloadable!] 2008 Cost-Effectiveness Analyses of Vaccination Programmes: A Focused Review of Modelling Approaches by Sun-Young Kim & Sue J. Goldie [Downloadable!] 2008 Projecting Vaccine Efficacy: Accounting for Geographic Strain Variations by Johnie Rose & Mendel E. Singer [Downloadable!] 2008 Transparency of Economic Evaluations of Health Technologies by Joan Rovira [Downloadable!] 2008 Meandering Down the Road to Transparency by Christopher I. Carswell & Joseph A. Paladino [Downloadable!] 2008 Management of Anaemia: A Critical and Systematic Review of the Cost Effectiveness of Erythropoiesis-Stimulating Agents by Mei Sheng Duh & Jennifer R. Weiner & Leigh Ann White & Patrick Lefebvre & Paul E. Greenberg [Downloadable!] 2008 Having Your Cake and Eating It: Office of Fair Trading Proposal for Funding New Drugs to Benefit Patients and Innovative Companies by Brian Godman & Alan Haycox & Ulrich Schwabe & Roberta Joppi & Silvio Garattini [Downloadable!] 2008 Non-Traditional Settings for Influenza Vaccination of Adults: Costs and Cost Effectiveness by Lisa A. Prosser & Megan A. OBrien & Noelle-Angelique M. Molinari & Katherine H. Hohman & Kristin L. Nichol & Mark L. Messonnier & Tracy A. Lieu [Downloadable!] 2008 The Burden of Schizophrenia on Caregivers: A Review by A. George Awad & Lakshmi N.P. Voruganti [Downloadable!] 2008 Modelling Methods for Pharmacoeconomics and Health Technology Assessment: An Overview and Guide by James E. Stahl [Downloadable!] 2008 Economic Burden of Psoriatic Arthritis by Christoph Ackermann & Arthur Kavanaugh [Downloadable!] 2008 Cost Effectiveness of Itraconazole in the Prophylaxis of Invasive Fungal Infections by Robin de Vries & Simon Daenen & Keith Tolley & Axel Glasmacher & Archie Prentice & Sarah Howells & Hariette Christopherson & Lolkje T.W. de Jong-van den Berg & Maarten J. Postma [Downloadable!] 2008 Economic Burden of Bilateral Neovascular Age-Related Macular Degeneration: Multi-Country Observational Study by Alan F. Cruess & Gergana Zlateva & Xiao Xu & Gisele Soubrane & Daniel Pauleikhoff & Andrew Lotery & Jordi Mones & Ronald Buggage & Caroline Schaefer & Tyler Knight & Thomas F. Goss [Downloadable!] 2008 The Last Decade of Italian Pharmaceutical Policy: Instability or Consolidation? by Giovanni Fattore & Claudio Jommi [Downloadable!] 2008 Dynamic Modelling of Infectious Diseases: An Application to the Economic Evaluation of Influenza Vaccination by Roberto Pradas-Velasco & Fernando Antonanzas-Villar & Maria Puy Martinez-Zarate [Downloadable!] 2008 Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas: A Cost-Utility Analysis by Gabriel Rogers & Ruth Garside & Stuart Mealing & Martin Pitt & Rob Anderson & Matthew Dyer & Ken Stein & Margaret Somerville [Downloadable!] 2008 Cost-Effectiveness Analyses of Hepatitis A Vaccine: A Systematic Review to Explore the Effect of Methodological Quality on the Economic Attractiveness of Vaccination Strategies by Andrea M. Anonychuk & Andrea C. Tricco & Chris T. Bauch & Ba' Pham & Vladimir Gilca & Bernard Duval & Ava John-Baptiste & Gloria Woo & Murray Krahn [Downloadable!] 2008 The New Myth: The Social Value of the QALY by Werner Brouwer & Job van Exel & Rachel Baker & Cam Donaldson [Downloadable!] 2007 Competition in a Pure World of Internet Telephony by Christoph Engel [Downloadable!] 2007 The Authors by Dominic P. Tilden & Segundo Mariz & Gillies OBryan-Tear & Julia Bottomley & Alexander Diamantopoulos [Downloadable!] 2007 A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK by Philip Home & Adrian Bagust & Matthew Taylor & Philip Ambery & Samara Mendes da Costa [Downloadable!] 2007 Reliability of Medicaid Claims Versus Medical Record Data: In a Cost Analysis of Palivizumab by Julie Jacobson Vann & John Feaganes & Steven Wegner [Downloadable!] 2007 Preferences of Community Pharmacists for Extended Roles in Primary Care: A Survey and Discrete Choice Experiment by Anthony Scott & Christine Bond & Jackie Inch & Aileen Grant [Downloadable!] 2007 Long-Term Clopidogrel Therapy in Patients Receiving Percutaneous Coronary Intervention by Bart M.S. Heeg & Ron J.G. Peters & Marc Botteman & Ben A. van Hout [Downloadable!] 2007 Epidemiology and Economic Impact of Meticillin-Resistant Staphylococcus aureus: Review and Analysis of the Literature by Andrew F. Shorr [Downloadable!] 2007 Modelling Disease Progression in Alzheimer by Colin Green [Downloadable!] 2007 The Increasingly Complex Fourth Hurdle for Pharmaceuticals by Joshua Cohen & Elly Stolk & Maartje Niezen [Downloadable!] 2007 Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children: Theoretical and Methodological Considerations by Lisa A. Prosser & James K. Hammitt & Ron Keren [Downloadable!] 2007 A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patients with Severe Chronic Obstructive Pulmonary Disease by Maureen P.M.H. Rutten-van Molken & Floortje E. van Nooten & Marion Lindemann & Manfred Caeser & Peter M.A. Calverley [Downloadable!] 2007 A Stated Preference Binary Choice Experiment to Explore NICE Decision Making by Paul Tappenden & John Brazier & Julie Ratcliffe & James Chilcott [Downloadable!] 2007 Direct Costs in Patients Hospitalised with Community-Acquired Pneumonia After Non-Response to Outpatient Treatment with Macrolide Antibacterials in the US by Joseph A. Paladino & Martin H. Adelman & Jerome J. Schentag & Paul B. Iannini [Downloadable!] 2007 Healthcare Utilisation and Costs Associated with Adding Montelukast to Current Therapy in Patients with Mild to Moderate Asthma and Co-Morbid Allergic Rhinitis: PRAACTICAL Study by Roberto Dal Negro & Peter Piskorz & Roberto Vives & Magda Guilera & Vasilisa Sazonov Kocevar & Xavier Badia [Downloadable!] 2007 The Contrast and Convergence of Bayesian and Frequentist Statistical Approaches in Pharmacoeconomic Analysis by Grant H. Skrepnek [Downloadable!] 2007 Impact of Pharmaceutical Prior Authorisation Policies: A Systematic Review of the Literature by Jaume Puig-Junoy & Ivan Moreno-Torres [Downloadable!] 2007 When Drugs Don't Work: Economic Assessment of Enhancing Compliance with Interventions Supported by Electronic Monitoring Devices by Dyfrig Hughes [Downloadable!] 2007 Cost-Utility Analysis in China: Differences and Difficulties Compared with Developed Countries by Liu Bao Peng & Chong Qing Tan & Xiao Min Wan & Wei Cui [Downloadable!] 2007 Direct and Indirect Costs Attributable to Alcohol Consumption in Germany by Alexander Konnopka & Hans-Helmut Konig [Downloadable!] 2007 The Use of Disease-Specific Outcome Measures in Cost-Utility Analysis: The Development of Dutch Societal Preference Weights for the FACT-L Scale by Leida M. Lamers & Carin A. Uyl-de Groot & Ivonne Buijt [Downloadable!] 2007 A Cost-Effectiveness Analysis of First-Line Controller Therapies for Persistent Asthma by Ya-Chen Tina Shih & Josephine Mauskopf & Rohit Borker [Downloadable!] 2007 Retrospective Economic and Outcomes Analyses Using Non-US Databases: A Review by Lizheng Shi & Eric Q Wu & Meredith Hodges & Andrew Yu & Howard Birnbaum [Downloadable!] 2007 Cost Considerations in the Treatment of Colorectal Cancer by Frank G.A. Jansman & Maarten J. Postma & Jacobus R.B.J. Brouwers [Downloadable!] 2007 Perspectives on Dynamic Optimisation and Control Theory in Treating Hyperlipidaemia by John A. Vernon [Downloadable!] 2007 Being Led Down the Wrong Garden PATH: the Importance of Knowledge and Facts for the Crossroads by Ron Goeree & Daria OReilly & Jean-Eric Tarride & Jim Bowen & Gord Blackhouse & Kaitryn Campbell & Rob Hopkins & Morgan Lim & Lisa Patterson [Downloadable!] 2007 Building Bridges Between Academic Research and Policy Formulation: When Costing Less Means Costing More by Amiram Gafni & Stephen Birch [Downloadable!] 2007 Costs and Benefits of Direct-to-Consumer Advertising: The Case of Depression by Adam E. Block [Downloadable!] 2007 Cost Effectiveness of Oseltamivir Treatment for Patients with Influenza-Like Illness Who Are at Increased Risk for Serious Complications of Influenza: Illustration for The Netherlands by Maarten J. Postma & Annoesjka Novak & Huib W.K.F.H. Scheijbeler & Marlene Gyldmark & Marianne L.L. van Genugten & Jan C. Wilschut [Downloadable!] 2007 Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs: A Retrospective Analysis among Managed Care Patients with Chronic Myelogenous Leukaemia by Theodore Darkow & Henry J. Henk & Simu K. Thomas & Weiwei Feng & Jean-Francois Baladi & George A. Goldberg & Alan Hatfield & Jorge Cortes [Downloadable!] 2007 A Systematic Review of Economic Evaluation Literature in Thailand: Are the Data Good Enough to be Used by Policy-Makers? by Yot Teerawattananon & Steve Russell & Miranda Mugford [Downloadable!] 2007 Estimation, Power and Sample Size Calculations for Stochastic Cost and Effectiveness Analysis by S.D. Walter & Amiram Gafni & Stephen Birch [Downloadable!] 2007 Reform of Prescription Drug Reimbursement and Pricing in the German Social Health Insurance Market: A Comparison of Three Scenarios by Stefan Gress & Dea Niebuhr & Uwe May & Jurgen Wasem [Downloadable!] 2007 Cost Effectiveness of Trastuzumab in the Adjuvant Treatment of Early Breast Cancer: A Lifetime Model by J. Alasdair Millar & Michael J. Millward [Downloadable!] 2007 Economic Evaluation of Treatment Administration Strategies of Ganciclovir for Cytomegalovirus Retinitis in HIV/AIDS Patients in Thailand: A Simulation Study by Kanlaya Teerawattananon & Saniorn Iewsakul & Chawewan Yenjitr & Somsanguan Ausayakhun & Watanee Yenjitr & Miranda Mugford & Yot Teerawattananon [Downloadable!] 2007 Costs of a Community Pharmacist-Led Medicines Management Service for Patients with Coronary Heart Disease in England: Healthcare System and Patient Perspectives by Anthony Scott & Michela Tinelli & Christine Bond [Downloadable!] 2007 The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): Responsiveness to Change and English Language Validation by Peter Wahlqvist & Gordon H. Guyatt & David Armstrong & Alessio DeglInnocenti & Diane Heels-Ansdell & Samer El-Dika & Ingela Wiklund & Carlo A. Fallone & Lisa Tanser & Sander Veldhuyzen van Zanten & Peggy Austin & Alan N. Barkun & Naoki Chiba & Holger J. Schunemann [Downloadable!] 2007 Health Utilities Using the EQ-5D in Studies of Cancer by A. Simon Pickard & Caitlyn T. Wilke & Hsiang-Wen Lin & Andrew Lloyd [Downloadable!] 2007 Replace Pharmaceutical Patents Now by Earl L. Grinols & James W. Henderson [Downloadable!] 2007 Book Review by Adis International Limited [Downloadable!] 2007 Therapeutic Use of Granulocyte Colony-Stimulating Factors for Established Febrile Neutropenia: Effect on Costs from a Hospital Perspective by Leon E. Cosler & Adi Eldar-Lissai & Eva Culakova & Nicole M. Kuderer & David Dale & Jeffrey Crawford & Gary H. Lyman [Downloadable!] 2007 Cost Effectiveness of Once-Daily Oral Chelation Therapy with Deferasirox versus Infusional Deferoxamine in Transfusion-Dependent Thalassaemia Patients: US Healthcare System Perspective by Thomas E. Delea & Oleg Sofrygin & Simu K. Thomas & Jean-Francois Baladi & Pradyumna D. Phatak & Thomas D. Coates [Downloadable!] 2007 Pharmacoeconomics of Available Treatment Options for Metastatic Prostate Cancer by Steven B. Zeliadt & David F. Penson [Downloadable!] 2007 The Economic Implications of Glaucoma: A Literature Review by Jordana K. Schmier & Michael T. Halpern & Mechelle L. Jones [Downloadable!] 2007 Measuring Patient-Reported Outcomes in Solid Organ Transplant Recipients: An Overview of Instruments Developed to Date by Irina Cleemput & Fabienne Dobbels [Downloadable!] 2007 Letter From the Commissioner by John A. Vernon [Downloadable!] 2007 Modelling Cost Effectiveness of Insulin Glargine for the Treatment of Type 1 and 2 Diabetes in Canada by Daniel T. Grima & Melissa F. Thompson & Luc Sauriol [Downloadable!] 2007 Cost Effectiveness of an Adherence-Improving Programme in Hypertensive Patients by Danielle E.M. Brunenberg & Gwenn E.C. Wetzels & Patricia J. Nelemans & Carmen D. Dirksen & Johan L. Severens & Henri E.J.H. Stoffers & Jan S.A.G. Schouten & Martin H. Prins & Peter W. de Leeuw & Manuela A. Joore [Downloadable!] 2007 Recombinant Erythropoietin for Chemotherapy-Related Anaemia: Economic Value and Health-Related Quality-of-Life Assessment Using Direct Utility Elicitation and Discrete Choice Experiment Methods by Diego F. Ossa & Andrew Briggs & Emma McIntosh & Warren Cowell & Tim Littlewood & Mark Sculpher [Downloadable!] 2007 Do Drugs Reduce Utilisation of Other Healthcare Resources? by Pierre-Yves Cremieux & Pierre Ouellette & Patrick Petit [Downloadable!] 2007 Enzyme Replacement Therapy in Orphan and Ultra-Orphan Diseases: The Limitations of Standard Economic Metrics as Exemplified by Fabry-Anderson Disease by David F. Moore & Markus Ries & Evelyn L. Forget & Raphael Schiffmann [Downloadable!] 2007 Economic Evaluations of Cholesterol-Lowering Drugs: A Critical and Systematic Review by Pearl D. Gumbs & Monique W.M. Verschuren & Aukje K. Mantel-Teeuwisse & Ardine G. de Wit & Anthonius de Boer & Olaf H. Klungel [Downloadable!] 2007 Economic Evaluation and Decision Making: Reimbursing Trastuzumab in Early-Stage Breast Cancer by Steven Simoens [Downloadable!] 2007 Measuring Preferences for Cost-Utility Analysis: How Choice of Method May Influence Decision-Making by Christine M. McDonough & Anna N.A. Tosteson [Downloadable!] 2007 Is Medication Review by Pharmacists of Any Use? by Arnold G. Zermansky & Nick Freemantle [Downloadable!] 2007 Letter From the Commissioner by John A. Vernon [Downloadable!] 2007 Home-Based Medication Review in Older People: Is it Cost Effective? by Margaret Pacini & Richard D. Smith & Edward C.F. Wilson & Richard Holland [Downloadable!] 2007 Acute/Subacute Herpes Zoster: Healthcare Resource Utilisation and Costs in a Group of US Health Plans by Ralph P. Insinga & Robbin F. Itzler & James M. Pellissier [Downloadable!] 2007 Conjoint Analysis of French and German Parents by David Bishai & Roger Brice & Isabelle Girod & Aneta Saleh & Jenifer Ehreth [Downloadable!] 2007 Disease Burden of Overactive Bladder: Quality-of-Life Data Assessed Using ICI-Recommended Instruments by Ramandeep Basra & Con Kelleher [Downloadable!] 2007 A by Tracey H. Sach & Richard D. Smith & David K. Whynes [Downloadable!] 2007 Time Preferences for Health in Northern Tanzania: An Empirical Analysis of Alternative Discounting Models by Bjarne Robberstad & John Cairns [Downloadable!] 2007 Reducing the Societal Burden of Depression: A Review of Economic Costs, Quality of Care and Effects of Treatment by Julie M. Donohue & Harold Alan Pincus [Downloadable!] 2007 Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children: A UK Analysis by Mark J.C. Nuijten & Wolfgang Wittenberg & Maximilian Lebmeier [Downloadable!] 2007 A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK by Dominic P. Tilden & Segundo Mariz & Gillies O'Bryan-Tear & Julia Bottomley & Alexander Diamantopoulos [Downloadable!] 2007 Rates and Probabilities in Economic Modelling: Transformation, Translation and Appropriate Application by Rachael L. Fleurence & Christopher S. Hollenbeak [Downloadable!] 2007 Cost Effectiveness of a Pharmacy-Based Coaching Programme to Improve Adherence to Antidepressants by Judith E. Bosmans & Oscar H. Brook & Hein P.J. van Hout & Martine C. de Bruijne & Hugo Nieuwenhuyse & Lex M. Bouter & Wim A.B. Stalman & Maurits W. van Tulder [Downloadable!] 2007 Letter From the Commissioner's Office at the US FDA by John A. Vernon [Downloadable!] 2007 NICE Cost-Effectiveness Appraisal of Cholinesterase Inhibitors: Was the Right Question Posed? Were the Best Tools Used? by Denis Getsios & Kristen Migliaccio-Walle & Jaime J. Caro [Downloadable!] 2007 When NICE Says No! by Alan Haycox [Downloadable!] 2007 Acknowledgement by Adis International Limited [Downloadable!] 2007 Oral Antiplatelet Therapy in Secondary Prevention of Cardiovascular Events: An Assessment from the Payer by Bart Heeg & Joep Damen & Ben Van Hout [Downloadable!] 2007 Economic Evidence at the Local Level: Options for Making it More Useful by Kees van Gool & Gisselle Gallego & Marion Haas & Rosalie Viney & Jane Hall & Robyn Ward [Downloadable!] 2007 Atorvastatin: A Pharmacoeconomic Review of its Use in the Primary and Secondary Prevention of Cardiovascular Events by Greg L. Plosker & Katherine A. Lyseng-Williamson [Downloadable!] 2007 Recombinant Factor VIIa (Eptacog Alfa): A Pharmacoeconomic Review of its Use in Haemophilia in Patients with Inhibitors to Clotting Factors VIII or IX by Katherine A. Lyseng-Williamson & Greg L. Plosker [Downloadable!] 2007 The Economic Impact of Introducing Serotonin-Noradrenaline Reuptake Inhibitors into the Brazilian National Drug Formulary: Cost-Effectiveness and Budget-Impact Analyses by Marcio Machado & Michael Iskedjian & Ines A. Ruiz & Thomas R. Einarson [Downloadable!] 2007 Cost Effectiveness of Entecavir versus Lamivudine with Adefovir Salvage in HBeAg-Positive Chronic Hepatitis B by David L. Veenstra & Sean D. Sullivan & Lauren Clarke & Uche H. Iloeje & Eskinder Tafesse & Adrian Di Bisceglie & Kris V. Kowdley & Robert G. Gish [Downloadable!] 2007 Strategies for the Management of Suspected Heparin-Induced Thrombocytopenia: A Cost-Effectiveness Analysis by Amanda R. Patrick & Wolfgang C. Winkelmayer & Jerry Avorn & Michael A. Fischer [Downloadable!] 2007 Economic Evaluations of Calcineurin Inhibitors in Renal Transplantation: A Literature Review by Alec H. Miners & Guiqing Yao & James Raftery & Rod S. Taylor [Downloadable!] 2007 The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of Osteoporosis: A Structured Review of the Literature by Rachael L. Fleurence & Cynthia P. Iglesias & Jeanene M. Johnson [Downloadable!] 2007 It's Time to Choose the Study Design!: Net Benefit Analysis of Alternative Study Designs to Acquire Information for Evaluation of Health Technologies by Oren Shavit & Moshe Leshno & Assaf Goldberger & Amir Shmueli & Amnon Hoffman [Downloadable!] 2007 Warfarin Pharmacogenetics: Economic Considerations by Dyfrig A. Hughes & Munir Pirmohamed [Downloadable!] 2007 Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin: Economic Comparison in Adult and Adolescent Type 1 Diabetes Mellitus in Australia by Neale Cohen & Michael E. Minshall & Lyn Sharon-Nash & Katerina Zakrzewska & William J. Valentine & Andrew J. Palmer [Downloadable!] 2007 Cost Effectiveness of Pegaptanib for the Treatment of Age-Related Macular Degeneration in the UK by Sorrel E. Wolowacz & Neil Roskell & Steven Kelly & Fiona M. Maciver & Chris S. Brand [Downloadable!] 2007 Use of Bayesian Net Benefit Regression Model to Examine the Impact of Generic Drug Entry on the Cost Effectiveness of Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients by Ya-Chen Tina Shih & Nebiyou B. Bekele & Ying Xu [Downloadable!] 2007 A Comparison of the Cost Effectiveness of Pharmacotherapy or Surgery (Laparoscopic Fundoplication) in the Treatment of GORD by Laura Bojke & Edward Hornby & Mark Sculpher [Downloadable!] 2007 Valuing Children by Joseph A. Ladapo & Peter J. Neumann & Ron Keren & Lisa A. Prosser [Downloadable!] 2007 Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions: Why Uncertainty About the Outcome, Estimate and Willingness to Pay Matters by Jeffrey S. Hoch & Carolyn S. Dewa [Downloadable!] 2007 The Alliances of European Retailers and Their Effects in the Field of Marketing and Supply Chain by Carmen Balan [Downloadable!] 2007 Factores estratégicos de éxito de las empresas de inserción by José Luis Retolaza Ávalos & Maite Ruiz Roqueñi & Andrés Araujo de la Mata [Downloadable!] 2006 Principle of Uncertain Future by Alexander Harin [Downloadable!] 2006 A Rational Irrational Man? by Alexander Harin [Downloadable!] 2006 Competition as a Socially Desirable Dilemma by Christoph Engel [Downloadable!] 2006 Competition as a Socially Desirable Dilemma by Christoph Engel [Downloadable!] 2006 Local Heroes and Superstars - An Empirical Analysis of Star Attraction in German Soccer by Leif Brandes & Egon Franck & Stephan Nüesch [Downloadable!] 2006 The Authors by Adrian A. Bagust & Marc Evans & Sophie Beale & Philip Home & Andrew Perry & Murray Stewart & Arran Shearer & Alan Martin & Lisa Hulme & Andreas Liebl & Oliver Schoeffski & Anita Goertz & Javier Ampudia-Blasco & Belen Martinez-Lage & Isabel Perez Escolano & Gonzalo Paris [Downloadable!] 2006 Modelling Lifetime Metabolic Progression and Cost Effectiveness of Treatment Strategies for Type 2 Diabetes by Andrew J. Palmer & Craig J. Currie [Downloadable!] 2006 Missing Data Imputation in Quality-of-Life Assessment: Imputation for WHOQOL-BREF by Ting Hsiang Lin [Downloadable!] 2006 Public Funding of Bosentan for the Treatment of Pulmonary Artery Hypertension in Australia: Cost Effectiveness and Risk Sharing by John H. Wlodarczyk & Leslie G. Cleland & Anne M. Keogh & Keith D. McNeil & Kate Perl & Robert G. Weintraub & Trevor J. Williams [Downloadable!] 2006 Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996-2003 by Yue-Chune Lee & Ming-Chin Yang & Yu-Tung Huang & Chien-Hsiang Liu & Sun-Bing Chen [Downloadable!] 2006 Cost-of-Illness Studies: A Review of Current Methods by Ebere Akobundu & Jing Ju & Lisa Blatt & C. Daniel Mullins [Downloadable!] 2006 Using Discrete Choice Experiments within a Cost-Benefit Analysis Framework: Some Considerations by Emma McIntosh [Downloadable!] 2006 The Value of Thinly Spread QALYs by Duncan Mortimer [Downloadable!] 2006 Accuracy versus Transparency in Pharmacoeconomic Modelling: Finding the Right Balance by David M. Eddy [Downloadable!] 2006 US FDA Guidance: Apropos of PROs by Paul Kind [Downloadable!] 2006 National-Level Purchasing of Expensive Drugs is Increasing Pressure on the Hospital Drug Budget by Slobodan M. Jankovic & Nebojsa Milivojevic [Downloadable!] 2006 Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada by Michele Kohli & Cheryl Attard & Annette Lam & Daniel Huse & John Cook & Chantal Bourgault & Evo Alemao & Donald Yin & Michael Marentette [Downloadable!] 2006 Costs of Inflammatory Bowel Disease in Germany by Renee Stark & Hans-Helmut Konig & Reiner Leidl [Downloadable!] 2006 A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction by Mark Lamotte & Lieven Annemans & Pawel Kawalec & York Zoellner [Downloadable!] 2006 Pharmacoeconomic Analyses of Azathioprine, Methotrexate and Prospective Pharmacogenetic Testing for the Management of Inflammatory Bowel Disease by Virginia L. Priest & Evan J. Begg & Sharon J. Gardiner & Christopher M.A. Frampton & Richard B. Gearry & Murray L. Barclay & David W.J. Clark & Paul Hansen [Downloadable!] 2006 A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials by Darren J. Clayson & Diane J. Wild & Paul Quarterman & Isabelle Duprat-Lomon & Maria Kubin & Stephen Joel Coons [Downloadable!] 2006 Prostaglandin Analogues for the Treatment of Glaucoma and Ocular Hypertension: A Systematic Review of Economic Evidence by Michelle Orme & Annabel Boler [Downloadable!] 2006 Cost Effectiveness of Leukotriene Modifiers in Adults with Asthma by Pamela C. Heaton [Downloadable!] 2006 Clopidogrel: A Pharmacoeconomic Review of its Use in Patients with Non-ST Elevation Acute Coronary Syndromes by Katherine A. Lyseng-Williamson & Greg L. Plosker [Downloadable!] 2006 Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/Fluticasone plus Salbutamol in the Treatment of Asthma by Gunnar Johansson & Emma B. Andreasson & Per E. Larsson & Claus F. Vogelmeier [Downloadable!] 2006 Tapering Off Benzodiazepines in Long-Term Users: An Economic Evaluation by Richard C. Oude Voshaar & Paul F.M. Krabbe & Wim J.M.J. Gorgels & Eddy M.M. Adang & Anton J.L.M. van Balkom & Eloy H. van de Lisdonk & Frans G. Zitman [Downloadable!] 2006 Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) Questionnaire in Patients with Diabetes in a Multi-Ethnic Asian Country by Hwee-Lin Wee & Chee-Eng Tan & Su-Yen Goh & Shu-Chuen Li [Downloadable!] 2006 Hepatitis C: Cost of Illness and Considerations for the Economic Evaluation of Antiviral Therapies by John B. Wong [Downloadable!] 2006 Cost of Lung Cancer: A Methodological Review by Laurent Molinier & Christophe Combescure & Cristos Chouaid & Jean-Pierre Daures & Bruno Housset & Didier Fabre & Alain Grand & Alain Vergnenegre [Downloadable!] 2006 Developing Health-Related Quality-of-Life Instruments for Use in Asia: The Issues by Yin Bun Cheung & Julian Thumboo [Downloadable!] 2006 Economic Models of Antiretroviral Therapy: Searching for the Optimal Strategy by Fred J. Hellinger [Downloadable!] 2006 NICE Says No to Inhaled Insulin: What Lessons Should We Learn? by Nick Freemantle [Downloadable!] 2006 The Authors by Colin Green & Joanna Picot & Emma Loveman & Andrea Takeda & Jo Kirby & Andrew Clegg [Downloadable!] 2006 Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer by Nick Bosanquet & Andrew Yeates [Downloadable!] 2006 Is the Childhood Asthma Questionnaire a Good Measure of Health-Related Quality of Life of Asthmatic Children in Asia?: Validation Among Paediatric Patients with Asthma in Singapore by Lee-Yee Chong & Oh-Moh Chay & Li Shu-Chuen [Downloadable!] 2006 Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients: A Pharmacoeconomic Analysis by George Dranitsaris & Mark Vincent & Mark Crowther [Downloadable!] 2006 Cost Effectiveness of Enoxaparin as Prophylaxis against Venous Thromboembolic Complications in Acutely Ill Medical Inpatients: Modelling Study from the Hospital Perspective in Germany by Peter K. Schadlich & Michael Kentsch & Manfred Weber & Wolfgang Kammerer & Josef Georg Brecht & Vijay Nadipelli & Eduard Huppertz [Downloadable!] 2006 The Effects of Type 1 Diabetes and its Long-Term Complications on Physical and Mental Health Status by Jarmo Hahl & Helena Hamalainen & Tuula Simell & Olli Simell [Downloadable!] 2006 The Impact of Losartan on the Lifetime Incidence of End-Stage Renal Disease and Costs in Patients with Type 2 Diabetes and Nephropathy by George W. Carides & Shahnaz Shahinfar & Erik J. Dasbach & William F. Keane & William C. Gerth & Charles M. Alexander & William H. Herman & Barry M. Brenner & the RENAAL Investigators [Downloadable!] 2006 Healthcare Rationing in Spain: Framework, Descriptive Analysis and Consequences by Rosa Rodriguez-Monguio & Fernando Antonanzas Villar [Downloadable!] 2006 Pharmacoeconomics of Angiotensin II Antagonists in Type 2 Diabetic Patients with Nephropathy: Implications for Decision Making by Cornelis Boersma & Jarir Atthobari & Ron T. Gansevoort & Lolkje T.W. de Jong-Van den Berg & Paul E. de Jong & Dick de Zeeuw & Lieven J.P. Annemans & Maarten J. Postma [Downloadable!] 2006 The Authors' Reply by Lawrence D. Goldberg & John G. Walt [Downloadable!] 2006 Cost Considerations in the Medical Management of Glaucoma in the US: Estimated Yearly Costs and Cost Effectiveness of Bimatoprost Compared with Other Medications by Javier Soto [Downloadable!] 2006 Letrozole: A Pharmacoeconomic Review of its Use in Postmenopausal Women with Breast Cancer by Christopher Dunn & Susan J. Keam [Downloadable!] 2006 Economic Evaluation of Weekly Epoetin Alfa versus Biweekly Darbepoetin Alfa for Chemotherapy-Induced Anaemia: Evidence from a 16-Week Randomised Trial by Shelby D. Reed & Jasmina I. Radeva & Davey B. Daniel & Samir H. Mody & Jamie B. Forlenza & R. Scott McKenzie & Kevin A. Schulman [Downloadable!] 2006 Comprehensive Decision-Analytic Model and Bayesian Value-of-Information Analysis: Pentoxifylline in the Treatment of Chronic Venous Leg Ulcers by Cynthia P. Iglesias & Karl Claxton [Downloadable!] 2006 Encouraging Smokers to Quit: The Cost Effectiveness of Reimbursing the Costs of Smoking Cessation Treatment by Janneke Kaper & Edwin J. Wagena & Constant P. van Schayck & Johan L. Severens [Downloadable!] 2006 Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: Based on Data from the Medical Research Council LU19 Trial by Laura Bojke & Mark Sculpher & Richard Stephens & Wendi Qian & Nick Thatcher & David Girling [Downloadable!] 2006 Cost Effectiveness of Preventive Interventions in Type 2 Diabetes Mellitus: A Systematic Literature Review by Sylvia M.C. Vijgen & Mirjam Hoogendoorn & Caroline A. Baan & G. Ardine de Wit & Wien Limburg & Talitha L. Feenstra [Downloadable!] 2006 Accounting for Tastes: A German Perspective on the Inclusion of Patient Preferences in Healthcare by Florian Vogt & David L.B. Schwappach & John F.P. Bridges [Downloadable!] 2006 The Authors by Richard J. Milne & Kathy H. Heaton-Brown & Paul Hansen & David Thomas & Vernon Harvey & Alison Cubitt [Downloadable!] 2006 Quality-of-Life Valuations of Advanced Breast Cancer by New Zealand Women by Stephanie Land [Downloadable!] 2006 Productivity Costs in Health-State Valuations: Does Explicit Instruction Matter? by Marieke Krol & Werner Brouwer & Pedram Sendi [Downloadable!] 2006 A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy by Aslam H. Anis & Huiying Sun & Sonia Singh & John Woolcott & Bohdan Nosyk & Marc Brisson [Downloadable!] 2006 Post-Exposure Influenza Prophylaxis with Oseltamivir: Cost Effectiveness and Cost Utility in Families in the UK by Beate Sander & Frederick G. Hayden & Marlene Gyldmark & Louis P. Garrison [Downloadable!] 2006 Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment: A Review and Consolidation of Quality Assessment by Zoe Philips & Laura Bojke & Mark Sculpher & Karl Claxton & Su Golder [Downloadable!] 2006 Optimal Assignment of Treatments to Health States Using a Markov Decision Model: An Introduction to Basic Concepts by Mohan V. Bala & Josephine A. Mauskopf [Downloadable!] 2006 Economic and Developmental Considerations for Pharmacogenomic Technology by John A. Vernon & Scott J. Johnson & W. Keener Hughen & Antonio Trujillo [Downloadable!] 2006 The Burden of Age-Related Macular Degeneration by Jordana K. Schmier & Mechelle L. Jones & Michael T. Halpern [Downloadable!] 2006 Bernard S. Bloom, PhD by Henry A. Glick [Downloadable!] 2006 Rationing of Drugs for Rare Diseases by Dyfrig Hughes [Downloadable!] 2006 Bimatoprost: A Pharmacoeconomic Review of its Use in Open-Angle Glaucoma and Ocular Hypertension by Greg L. Plosker & Susan J. Keam [Downloadable!] 2006 The Authors' Reply by Paul Kind & Sue Macran [Downloadable!] 2006 Eliciting Social Preference Weights for Functional Assessment of Cancer Therapy-Lung Health States by A. Simon Pickard & Deborah Dobrez & David Cella [Downloadable!] 2006 Quality-of-Life Valuations of Advanced Breast Cancer by New Zealand Women by Richard J. Milne & Kathy H. Heaton-Brown & Paul Hansen & David Thomas & Vernon Harvey & Alison Cubitt [Downloadable!] 2006 Functional Impairment, Healthcare Costs and the Prevalence of Institutionalisation in Patients with Alzheimer's Disease and Other Dementias by Jerrold Hill & Howard Fillit & Simu K. Thomas & Sobin Chang [Downloadable!] 2006 Cost Considerations in the Medical Management of Glaucoma in the US: Estimated Yearly Costs and Cost Effectiveness of Bimatoprost Compared with Other Medications by Lawrence D. Goldberg & John Walt [Downloadable!] 2006 Cost Effectiveness of Extended Adjuvant Letrozole in Postmenopausal Women after Adjuvant Tamoxifen Therapy: The UK Perspective by Jonathan Karnon & Thomas Delea & Stephen R.D. Johnston & Robert Smith & Jane Brandman & Jennifer Sung & Paul E. Goss [Downloadable!] 2006 Trends in Outpatient Prescription Drug Use and Related Costs in the US: 1998-2003 by Diane K. Wysowski & Laura A. Governale & Joslyn Swann [Downloadable!] 2006 Aromatase Inhibitors in Breast Cancer: A Review of Cost Considerations and Cost Effectiveness by Jonathan Karnon [Downloadable!] 2006 Less is More: Medicines that Require Less Frequent Administration Improve Adherence, but Are They Better? by Dyfrig Hughes [Downloadable!] 2006 How Much is the Cost of Visual Impairment: the Author's Reply by Antoine Lafuma [Downloadable!] 2006 How Much is the Cost of Visual Impairment: Caveat Emptor by Catherine Meads & Chris Hyde [Downloadable!] 2006 Evaluation of Non-Medical Costs Associated with Visual Impairment in Four European Countries: France, Italy, Germany and the UK by Antoine Lafuma & Antoine Brezin & Stefania Lopatriello & Klaus Hieke & Julia Hutchinson & Viviane Mimaud & Gilles Berdeaux [Downloadable!] 2006 The Long-Term Cost Effectiveness of Treatments for Benign Prostatic Hyperplasia by Rachael L. DiSantostefano & Andrea K. Biddle & John P. Lavelle [Downloadable!] 2006 A Multi-Country Economic Evaluation of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease by Mark Lamotte & Lieven Annemans & Thomas Evers & Maria Kubin [Downloadable!] 2006 Combination Vaccine Against Invasive Meningococcal B and Pneumococcal Infections: Potential Epidemiological and Economic Impact in The Netherlands by Jasper M. Bos & Hans C. Rumke & Robert Welte & Lodewijk Spanjaard & Loek van Alphen & Maarten J. Postma [Downloadable!] 2006 Differential Effects of Atypical versus Typical Antipsychotic Medication on Earnings of Schizophrenia Patients: Estimates from a Prospective Naturalistic Study by David Salkever & Eric Slade & Mustafa Karakus [Downloadable!] 2006 Sociodemographic Differences in Quality of Life in Rheumatoid Arthritis by Erik J. Groessl & Theodore G. Ganiats & Andrew J. Sarkin [Downloadable!] 2006 Better Analysis for Better Decisions: Has Pharmacoeconomics Come of Age? by Michael Drummond & Mark Sculpher [Downloadable!] 2006 Economic Evaluation of Rivastigmine in Patients with Parkinson's Disease Dementia by Andrew R. Willan & Ron Goeree & Eleanor M. Pullenayegum & Christopher McBurney & Gordon Blackhouse [Downloadable!] 2006 Cost Effectiveness of Bemiparin Sodium versus Unfractionated Heparin and Oral Anticoagulants in the Acute and Long-Term Treatment of Deep Vein Thrombosis by Antonio Gomez-Outes & Eduardo Rocha & Javier Martinez-Gonzalez & Vijay V. Kakkar [Downloadable!] 2006 Evaluation of the Cost Effectiveness of Sirolimus versus Tacrolimus for Immunosuppression Following Renal Transplantation in the UK by Phil McEwan & Simon Dixon & Keshwar Baboolal & Pete Conway & Craig J. Currie [Downloadable!] 2006 Interstitial Cystitis: Cost, Treatment and Co-morbidities in an Employed Population by Eric Q. Wu & Howard Birnbaum & Milena Mareva & Andrew Parece & Zihong Huang & David Mallett & Haya Taitel [Downloadable!] 2006 Incorporating Carer Effects into Economic Evaluation by Simon Dixon & Mel Walker & Sam Salek [Downloadable!] 2006 Too Important to Ignore: Informal Caregivers and Other Significant Others by Werner B.F. Brouwer [Downloadable!] 2006 Costs of Irritable Bowel Syndrome in the UK and US by Stefanie Maxion-Bergemann & Frank Thielecke & Florian Abel & Rito Bergemann [Downloadable!] 2006 Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis by A.E. Ades & Mark Sculpher & Alex Sutton & Keith Abrams & Nicola Cooper & Nicky Welton & Guobing Lu [Downloadable!] 2006 The Authors by J.M. Bos & M.J. Postma & L. Annemans [Downloadable!] 2006 Discounting Health Effects in Pharmacoeconomic Evaluations: Current Controversies by Stuart Birks [Downloadable!] 2006 Candesartan Cilexetil: A Pharmacoeconomic Review of its Use in Chronic Heart Failure and Hypertension by Greg L. Plosker & Susan J. Keam [Downloadable!] 2006 Association of Co-Morbidities with Prescribing Patterns and Cost Savings: Olanzapine versus Risperidone for Schizophrenia by Wei Yu & Xinhua S. Ren & Austin F. Lee & Lawrence Herz & Yu-Hui Huang & Lewis E. Kazis [Downloadable!] 2006 Cost Effectiveness of Tumour Necrosis Factor-alpha Inhibitors as First-Line Agents in Rheumatoid Arthritis by James R. Spalding & Joel Hay [Downloadable!] 2006 Generic Health-Related Quality-of-Life Assessment in Children and Adolescents: Methodological Considerations by Ulrike Ravens-Sieberer & Michael Erhart & Nora Wille & Ralf Wetzel & Jennifer Nickel & Monika Bullinger [Downloadable!] 2006 Assessing Generalisability in Model-Based Economic Evaluation Studies: A Structured Review in Osteoporosis by Hege Urdahl & Andrea Manca & Mark J. Sculpher [Downloadable!] 2006 Letter From the Commissioner's Office at the US FDA by John A. Vernon [Downloadable!] 2006 Do Pharmacogenomic Tests Provide Value to Policy Makers? by Ya-Chen Tina Shih & Lajos Pusztai [Downloadable!] 2006 Acknowledgement by Adis International Limited [Downloadable!] 2006 Economic Evaluation in the US: What is the Missing Link? by Peter J. Neumann & Sean D. Sullivan [Downloadable!] 2006 Economic Evaluations in the Canadian Common Drug Review by Andreas Laupacis [Downloadable!] 2006 Building Bridges Between Academic Research and Policy Formulation: The PRUFE Framework - an Integral Part of Ontario by Ron Goeree & Leslie Levin [Downloadable!] 2006 Economic Evaluation and Decision Making in the UK by Martin J. Buxton [Downloadable!] 2006 Information Created to Evade Reality (ICER): Things We Should Not Look to for Answers by Stephen Birch & Amiram Gafni [Downloadable!] 2006 Conference Paper by Andrea Manca & Andrew R. Willan [Downloadable!] 2006 Analysis Sans Frontieres: Can We Ever Make Economic Evaluations Generalisable Across Jurisdictions? by Mark J. Sculpher & Michael F. Drummond [Downloadable!] 2006 Pharmacoeconomics and Pharmacoepidemiology: Curious Bedfellows or a Match Made in Heaven? by Andrew H. Briggs & Adrian R. Levy [Downloadable!] 2006 Utility Measurement in Healthcare: The Things I Never Got To by George W. Torrance [Downloadable!] 2006 Using Value of Information Analysis to Prioritise Health Research: Some Lessons from Recent UK Experience by Karl P. Claxton & Mark J. Sculpher [Downloadable!] 2006 Recent Developments in Decision-Analytic Modelling for Economic Evaluation by Milton C. Weinstein [Downloadable!] 2006 Better Analysis for Better Decisions: Facing Up to the Challenges by Michael F. Drummond & Mark J. Sculpher [Downloadable!] 2006 Hospitalisation Costs of Cystic Fibrosis by Jonas Schreyogg & Helge Hollmeyer & Miriam Bluemel & Doris Staab & Reinhard Busse [Downloadable!] 2006 Disability and Quality of Life in Post-Traumatic Stress Disorder: Impact of Drug Treatment by Soraya Seedat & Christine Lochner & Bavanisha Vythilingum & Dan J. Stein [Downloadable!] 2006 Single-Inhaler Combination Therapy for Asthma: A Review of Cost Effectiveness by Manabu Akazawa & David A. Stempel [Downloadable!] 2006 Therapeutic Options for the Prevention and Treatment of Postoperative Nausea and Vomiting: A Pharmacoeconomic Review by Jean Lachaine [Downloadable!] 2006 Should We Abandon QALYs as a Resource Allocation Tool? by Sandeep Vijan [Downloadable!] 2006 QALYs: Are They Helpful to Decision Makers? by Maurice McGregor & J. Jaime Caro [Downloadable!] 2006 The Generalisability of Pharmacoeconomic Studies: Issues and Challenges Ahead by James M. Mason & Anne R. Mason [Downloadable!] 2006 Anticoagulation for Stroke Prevention: High Effectiveness, More Cost Benefit? by Eduard Shantsila & Timothy Watson & Gregory Y.H. Lip [Downloadable!] 2006 The Cost Effectiveness of Anticoagulation Management Services for Patients with Atrial Fibrillation and at High Risk of Stroke in the US by Patrick W. Sullivan & Thomas W. Arant & Samuel L. Ellis & Heather Ulrich [Downloadable!] 2006 The Initial Validation of a Markov Model for the Economic Evaluation of (New) Treatments for Rheumatoid Arthritis by Paco M.J. Welsing & Johan L. Severens & Margriet Hartman & Anke M. van Gestel & Piet L.C.M. van Riel & Roland F.J.M. Laan [Downloadable!] 2005 Fair Behavior and Inflation Persistence by Seidel, Gerald [Downloadable!] 2005 Reform of Building Regulation by Productivity Commission [Downloadable!] 2005 Scientific Revolution. A Farewell to EconWPA by Alexander Harin [Downloadable!] 2005 Stochastic Market Sharing, Partial Communication and Collusion by Heiko Gerlach [Downloadable!] 2005 Gains and losses. The same or different choices? by Alexander Harin [Downloadable!] 2005 A new approach to solve old problems by Alexander Harin [Downloadable!] 2005 The Governance of Occupational Pension Funds and the Politico- Economic Implications: The Case of Austria by Stefan W. Schmitz [Downloadable!] 2005 Raison d'être et spécificités de la firme bancaire : pourquoi la banque n'est-elle pas une entreprise comme les autres ? by dhafer saidane [Downloadable!] 2005 Optimal Taxation of Gambling and Lotto by Walther Herbert [Downloadable!] 2005 Asymptotic Distribution Theory of Empirical Rank-dependent Measures of Inequality by Rolf Aaberge [Downloadable!] 2005 U.S. Inequality: Debt Constraints or Incomplete Markets? by Juan Carlos Cordoba [Downloadable!] 2005 Voice over IP. Competition Policy and Regulation by christoph Engel [Downloadable!] 2005 Explaining de facto Judicial Independence by Bernd Hayo and Stefan Voigt [Downloadable!] 2005 Explaining de facto Judicial Independence by Bernd Hayo and Stefan Voigt [Downloadable!] 2005 Book Review by Adis International Limited [Downloadable!] 2005 Linezolid: A Pharmacoeconomic Review of its Use in Serious Gram-Positive Infections by Greg L. Plosker & David P. Figgitt [Downloadable!] 2005 Cost Effectiveness of Dalteparin for Preventing Venous Thromboembolism in Abdominal Surgery by Adrienne Heerey & Sanjeev Suri [Downloadable!] 2005 Cost-Benefit Analysis of Vaccination against Tick-Borne Encephalitis among French Troops by Guillaume Desjeux & Laurent Galoisy-Guibal & Cyrille Colin [Downloadable!] 2005 A Systematic Review of Patient-Reported Outcome Instruments Measuring Sleep Dysfunction in Adults by Emily Beth Devine & Zafar Hakim & Jesse Green [Downloadable!] 2005 Economic Implications of Biological Therapies for Crohn by Keith Bodger [Downloadable!] 2005 The Role of Economic Evaluation in Vaccine Decision Making: Focus on Meningococcal Group C Conjugate Vaccine by Robert Welte & Caroline L. Trotter & W. John Edmunds & Maarten J. Postma & Philippe Beutels [Downloadable!] 2005 The Authors' Reply by Anthony O'Hagan & Christopher McCabe & Ron Akehurst & Alan Brennan & Andrew Briggs & Karl Claxton & Elisabeth Fenwick & Dennis Fryback & Mark Sculpher & David Spiegelhalter & Andrew Willan [Downloadable!] 2005 Incorporation of Uncertainty in Health Economic Modelling Studies by Mark Nuijten [Downloadable!] 2005 An Economic Evaluation of Rizatriptan in the Treatment of Migraine by Melissa Thompson & Marek Gawel & Brigitte Desjardins & Nicole Ferko & Daniel Grima [Downloadable!] 2005 Cost of Illness and its Predictors for Parkinson's Disease in Germany by Annika E. Spottke & Martin Reuter & Olaf Machat & Bernhard Bornschein & Sonja von Campenhausen & Karin Berger & Rudolf Koehne-Volland & Jurgen Rieke & Alexander Simonow & Dirk Brandstaedter & Uwe Siebert & Wolfgang H. Oertel & Gudrun Ulm & Richard Dodel [Downloadable!] 2005 Economic Evaluation of Temozolomide in the Treatment of Recurrent Glioblastoma Multiforme by Janne A. Martikainen & Akseli Kivioja & Taru Hallinen & Pia Vihinen [Downloadable!] 2005 Societal Discounting of Health Effects in Cost-Effectiveness Analyses: The Influence of Life Expectancy by Suzanne Polinder & Willem Jan Meerding & Job van Exel & Werner Brouwer [Downloadable!] 2005 Parent-Proxy EQ-5D Ratings of Children with Attention-Deficit Hyperactivity Disorder in the US and the UK by Louis S. Matza & Kristina Secnik & Sally Mannix & F. Randy Sallee [Downloadable!] 2005 Granulocyte Colony-Stimulating Factor for Chemotherapy-Induced Neutropenia in Patients with Small Cell Lung Cancer: The 40% Rule Revisited by Elizabeth A. Calhoun & Glen T. Schumock & June M. McKoy & Simon Pickard & Karen A. Fitzner & Elizabeth A. Heckinger & Eowyn F. Powell & Kathyrn R. McCaffrey & Charles L. Bennett [Downloadable!] 2005 Pharmaceutical Policy regarding Generic Drugs in Belgium by Steven Simoens & Kristien De Bruyn & Marc Bogaert & Gert Laekeman [Downloadable!] 2005 Real-World Trials to Answer Real-World Questions by Nick Freemantle & Lawrence Blonde & Bjorn Bolinder & Robert A. Gerber & F.D. Richard Hobbs & Luc Martinez & Stuart Ross [Downloadable!] 2005 The Authors' Reply by Andrew Moore & Ceri Phillips & Elke Hunsche & James Pellissier & Simone Crespi [Downloadable!] 2005 Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK by Eduardo Carracedo-Martinez [Downloadable!] 2005 Costs and Medical Care Consequences Associated with the Diagnosis of Peripheral Arterial Disease by Kristen Migliaccio-Walle & J. Jaime Caro & Khajak J. Ishak & Judith A. OBrien [Downloadable!] 2005 Economic Assessment of Adjustable Maintenance Treatment with Budesonide/Formoterol in a Single Inhaler versus Fixed Treatment in Asthma by Bernd Bruggenjurgen & Dagmar Selim & Peter Kardos & Kai Richter & Claus Vogelmeier & Stephanie Roll & Wolfgang Meyer-Sabellek & Roland Buhl & Stefan N Willich [Downloadable!] 2005 Introducing Economic Evaluation as a Policy Tool in Korea: Will Decision Makers get Quality Information?: A Critical Review of Published Korean Economic Evaluations by Kun-Sei Lee & Werner B.F. Brouwer & Sang-Il Lee & Hye-Won Koo [Downloadable!] 2005 The State of Patient-Reported Outcomes in Atrial Fibrillation: A Review of Current Measures by Karin Coyne & Mary Kay Margolis & Susan Grandy & Peter Zimetbaum [Downloadable!] 2005 Evaluating Health-Related Quality-of-Life Studies in Paediatric Populations: Some Conceptual, Methodological and Developmental Considerations and Recent Applications by Mirella De Civita & Dean Regier & Abul H. Alamgir & Aslam H. Anis & Mark J. FitzGerald & Carlo A. Marra [Downloadable!] 2005 Price Differentiation and Transparency in the Global Pharmaceutical Marketplace by David B. Ridley [Downloadable!] 2005 Discounting Health Effects in Pharmacoeconomic Evaluations: Current Controversies by J.M. Bos & Maarten J. Postma & Lieven Annemans [Downloadable!] 2005 Development of an Economic Model to Assess the Cost Effectiveness of Treatment Interventions for Chronic Obstructive Pulmonary Disease by Michael Spencer & Andrew H. Briggs & Ronald F. Grossman & Laureen Rance [Downloadable!] 2005 The Cost Effectiveness of Infliximab for Severe Treatment-Resistant Rheumatoid Arthritis in the UK by Marco Barbieri & John B. Wong & Michael Drummond [Downloadable!] 2005 Pharmacoeconomic Evaluation of Antidepressants: A Critical Appraisal of Methods by Sheikh Usman Iqbal & Mark Prashker [Downloadable!] 2005 Bipolar Disorder and Health-Related Quality of Life: Review of Burden of Disease and Clinical Trials by Dennis A. Revicki & Louis S. Matza & Emuella Flood & Andrew Lloyd [Downloadable!] 2005 Remission from Depression: A Review of Venlafaxine Clinical and Economic Evidence by Donald Han & Edward C.Y. Wang [Downloadable!] 2005 The Economics of Topical Immunomodulators for the Treatment of Atopic Dermatitis by William Abramovits & Mark Boguniewicz & Amy S. Paller & Diane L. Whitaker-Worth & Mary M. Prendergast & Michael Tokar & Kuo B. Tong [Downloadable!] 2005 Health Utilities in Alzheimer by Peter J. Neumann [Downloadable!] 2005 Incorporation of Uncertainty in Health Economic Modelling Studies by Anthony OHagan & Christopher McCabe & Ron Akehurst & Alan Brennan & Andrew Briggs & Karl Claxton & Elisabeth Fenwick & Dennis Fryback & Mark Sculpher & David Spiegelhalter & Andrew Willan [Downloadable!] 2005 On Pharmacogenomics and Cost-Effectiveness Analysis at the Individual Level by Mohan V. Bala & Gary A. Zarkin [Downloadable!] 2005 Cost Effectiveness of Imatinib Compared with Interferon-alpha or Hydroxycarbamide for First-Line Treatment of Chronic Myeloid Leukaemia by Kim Dalziel & Ali Round & Ruth Garside & Ken Stein [Downloadable!] 2005 Reductions in Anaemia and Fatigue are Associated with Improvements in Productivity in Cancer Patients Receiving Chemotherapy by Ernst Berndt & Joel Kallich & Anne McDermott & Xiao Xu & Howard Lee & John Glaspy [Downloadable!] 2005 Economic Evaluation of Levetiracetam as an Add-On Therapy in Patients with Refractory Epilepsy by Lucie Blais & Odile Sheehy & Jean-Marc Saint-Hilaire & Gilles-Pierre Bernier & Philippe Godfroid & Jacques LeLorier [Downloadable!] 2005 Economic Considerations in the Prescribing of Third-Generation Antidepressants by Stuart Montgomery & John J. Doyle & Lee Stern & Christopher R. McBurney [Downloadable!] 2005 The Health-Related Quality of Life and Economic Burden of Constipation by Cheryl Dennison & Manishi Prasad & Andrew Lloyd & Samir K. Bhattacharyya & Ravinder Dhawan & Karin Coyne [Downloadable!] 2005 Valuing Patient and Caregiver Time: A Review of the Literature by Jennifer E. Tranmer & Denise N. Guerriere & Wendy J. Ungar & Peter C. Coyte [Downloadable!] 2005 Does Pharmacogenomics Provide an Ethical Challenge to the Utilisation of Cost-Effectiveness Analysis by Public Health Systems? by Adam La Caze [Downloadable!] 2005 Effects of Antidepressants on Quality of Life in Women with Premenstrual Dysphoric Disorder by Ellen W. Freeman [Downloadable!] 2005 Willingness to Pay for a QALY: Theoretical and Methodological Issues by Dorte Gyrd-Hansen [Downloadable!] 2005 Quality Control in the Regulation of Pharmaceuticals by Alan Maynard [Downloadable!] 2005 Modelling Cost Effectiveness and Cost Utility of Sequential DMARD Therapy Including Leflunomide for Rheumatoid Arthritis in Germany: II. The Contribution of Leflunomide to Efficiency by Peter K. Schadlich & Henning Zeidler & Angela Zink & Erika Gromnica-Ihle & Matthias Schneider & Christoph Straub & Josef G. Brecht & Eduard Huppertz [Downloadable!] 2005 Modelling Cost Effectiveness and Cost Utility of Sequential DMARD Therapy Including Leflunomide in Rheumatoid Arthritis in Germany: I. Selected DMARDs and Patient-Related Costs by Peter K. Schadlich & Henning Zeidler & Angela Zink & Erika Gromnica-Ihle & Matthias Schneider & Christoph Straub & Josef G. Brecht & Eduard Huppertz [Downloadable!] 2005 Cost Effectiveness of Budesonide/Formoterol in a Single Inhaler for COPD Compared with Each Monocomponent Used Alone by Claes-Goran Lofdahl & Asa Ericsson & Klas Svensson & Emma Andreasson [Downloadable!] 2005 Health-Related QOL in Acute Exacerbations of Chronic Bronchitis and Chronic Obstructive Pulmonary Disease: A Review of the Literature by Helen Doll & Marc Miravitlles [Downloadable!] 2005 Review of the Cost Effectiveness of Immunisation Strategies for the Control of Epidemic Meningococcal Meningitis by Mark A. Miller & Cathryn K. Shahab [Downloadable!] 2005 Pharmacoeconomic Analyses Using Discrete Event Simulation by J. Jaime Caro [Downloadable!] 2005 Future Challenges for the Economic Evaluation of Healthcare: Patient Preferences, Risk Attitudes and Beyond by John F.P. Bridges [Downloadable!] 2005 Meningococcal Vaccination: Cui Bono? by Thomas D. Szucs [Downloadable!] 2005 Cost-Effectiveness Model Of Long-Acting Risperidone in Schizophrenia in the US by Natalie C. Edwards & Marcia F.T. Rupnow & Chris L. Pashos & Marc F. Botteman & Ronald J. Diamond [Downloadable!] 2005 The Case of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Rheumatoid Arthritis: A Budget Impact Analysis by Jan Sorensen & Lis S. Andersen [Downloadable!] 2005 A Pharmacoeconomic Evaluation of Statins in the Treatment of Hypercholesterolaemia in the Primary Care Setting in Spain by Pedro J. Tarraga-Lopez & Angel Celada-Rodriguez & Miguel Cerdan-Oliver & Juan Solera-Albero & Jose M Ocana-Lopez & Mateo A. Lopez-Cara & Jaime De Miguel-Clave [Downloadable!] 2005 Oral Serotonin Receptor Agonists: A Review of Their Cost Effectiveness in Migraine by Jennifer H. Lofland & David B. Nash [Downloadable!] 2005 International Variation in Resource Utilisation and Treatment Costs for Rheumatoid Arthritis: A Systematic Literature Review by Hubertus Rosery & Rito Bergemann & Stefanie Maxion-Bergemann [Downloadable!] 2005 The Economic Impact of Neuropsychiatric Symptoms in Alzheimer by Daniel L. Murman & Christopher C. Colenda [Downloadable!] 2005 Penny and Pound Wise: Pharmacoeconomics from a Governmental Perspective by Mike F. van Oostenbruggen & Ronald B. Jansen & Katja Mur & Huib Kooijman [Downloadable!] 2005 The Relationship between Productivity and Health-Related QOL: An Exploration by Werner B.F. Brouwer & Willem-Jan Meerding & Leida M. Lamers & Johan L. Severens [Downloadable!] 2005 EMEA: For Patients or For Industry? by Silvio Garattini [Downloadable!] 2005 Memantine: A Pharmacoeconomic Review of its Use in Moderate-to-Severe Alzheimer's Disease by Greg L. Plosker & Katherine A. Lyseng-Williamson [Downloadable!] 2005 The Impact of Anaemia and its Treatment on Employee Disability and Medical Costs by Ernst Berndt & William Crown & Joel Kallich & Stacey Long & Xue Song & Gary H. Lyman [Downloadable!] 2005 Cost-Minimisation Analysis of Sivelestat for Acute Lung Injury Associated with Systemic Inflammatory Response Syndrome by Naoki Aikawa & Seitaro Fujishima & Makoto Kobayashi & Shozo Matsuoka & Taira Abiru [Downloadable!] 2005 Evaluation of the Cost Effectiveness of Escitalopram versus Venlafaxine XR in Major Depressive Disorder by Jose-Luis Fernandez & Stuart Montgomery & Clement Francois [Downloadable!] 2005 Providing Systematic Guidance in Pharmacoeconomic Guidelines for Analysing Costs by Philip Jacobs & Arto Ohinmaa & Bruce Brady [Downloadable!] 2005 Cost Effectiveness of Treating Low HDL-Cholesterol in the Primary Prevention of Coronary Heart Disease by Joel W. Hay & Kimberly L. Sterling [Downloadable!] 2005 The Case for Stratified Cost-Effectiveness Analysis by Baseline Health-Related QOL: Theory and Sensitivity Analysis by Joseph Schaafsma [Downloadable!] 2005 The Diffusion of Health Economics Knowledge in Europe: The EURONHEED (European Network of Health Economics Evaluation Database) Project by Gerard de Pouvourville & Philippe Ulmann & John Nixon & Stephanie Boulenger & Julie Glanville & Michael Drummond [Downloadable!] 2005 The Friction-Cost Method: Replacement for Nothing and Leisure for Free? by Werner B.F. Brouwer & Marc A. Koopmanschap [Downloadable!] 2005 Friction-Cost Method as an Alternative to the Human-Capital Approach in Calculating Indirect Costs by Howard Birnbaum [Downloadable!] 2005 Comorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder by Kristina Secnik & Andrine Swensen & Maureen J. Lage [Downloadable!] 2005 A Randomised Trial of the Cost Effectiveness of Buprenorphine as an Alternative to Methadone Maintenance Treatment for Heroin Dependence in a Primary Care Setting by Anthony H. Harris & Elena Gospodarevskaya & Alison J. Ritter [Downloadable!] 2005 Q-TWiST Analysis of Cyclophosphamide, Epirubicin, Fluorouracil versus Cyclophosphamide, Methotrexate, Fluorouracil Treatment for Premenopausal Women with Node-Positive Breast Cancer by Davide Radice & Alberto Redaelli [Downloadable!] 2005 Household-Based Costs and Benefits of Vaccinating Healthy Children in Daycare Against Influenza Virus: Results from a Pilot Study by Maria Pisu & Martin I. Meltzer & Eugene S. Hurwitz & Michael Haber [Downloadable!] 2005 Measuring Productivity Changes in Economic Evaluation: Setting the Research Agenda by Marc Koopmanschap & Alex Burdorf & Karin Jacob & Willem Jan Meerding & Werner Brouwer & Hans Severens [Downloadable!] 2005 A Review of the Costs of Managing Childhood Epilepsy by Ettore Beghi & Barbara Frigeni & Massimiliano Beghi & Paola De Compadri & Livio Garattini [Downloadable!] 2005 Pharmacoeconomic Impact of Non-Compliance with Statins by Andrew M. Peterson & William F. McGhan [Downloadable!] 2005 Role of Pharmacoeconomic Analysis in R&D Decision Making: When, Where, How? by Paul Miller [Downloadable!] 2005 Rizatriptan: A Pharmacoeconomic Review of its Use in the Acute Treatment of Migraine by Paul L. McCormack & Rachel H. Foster [Downloadable!] 2005 Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer's Disease by Colin Green & Joanna Picot & Emma Loveman & Andrea Takeda & Jo Kirby & Andrew Clegg [Downloadable!] 2005 Pramipexole and Levodopa in Early Parkinson's Disease: Dynamic Changes in Cost Effectiveness by Katia Noyes & Andrew W. Dick & Robert G. Holloway & The Parkinson Study Group [Downloadable!] 2005 A Willingness-To-Pay Assessment of Parents' Preference for Shorter Duration Treatment of Acute Otitis Media in Children by Delphine Gueylard Chenevier & Jacques LeLorier [Downloadable!] 2005 Estimating Mean Total Costs in the Presence of Censoring: A Comparative Assessment of Methods by Tracey A. Young [Downloadable!] 2005 Willingness to Pay for Inhaled Insulin: A Contingent Valuation Approach by Hamid Sadri & Linda D. MacKeigan & Lawrence A. Leiter & Thomas R. Einarson [Downloadable!] 2005 Cost-Effectiveness Acceptability Curves and a Reluctance to Lose by Johan L. Severens & Danielle E.M. Brunenberg & Elisabeth A.L. Fenwick & Bernie O'Brien & Manuela A. Joore [Downloadable!] 2005 No Room for Kinkiness in a Public Healthcare System by Jack Dowie [Downloadable!] 2005 The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development - The Authors' Reply by Joseph A. DiMasi & Cherie Paquette [Downloadable!] 2005 Comment on by Aidan Hollis [Downloadable!] 2005 Acknowledgement by Adis International Limited [Downloadable!] 2005 The Importance of Drug Adverse Effects Compared with Seizure Control for People with Epilepsy: A Discrete Choice Experiment by Andrew Lloyd & Emma McIntosh & Martin Price [Downloadable!] 2005 Economic Evaluation of Three Two-Drug Chemotherapy Regimens in Advanced Non-Small-Cell Lung Cancer by Niels Neymark & Pilar Lianes & Egbert F. Smit & Jan P. van Meerbeeck [Downloadable!] 2005 Eliciting Social Preference Weights for Functional Assessment of Cancer Therapy-Lung Health States by Paul Kind & Susan Macran [Downloadable!] 2005 Acute Pyelonephritis Among Adults: Cost of Illness and Considerations for the Economic Evaluation of Therapy by Patricia Brown & Moran Ki & Betsy Foxman [Downloadable!] 2005 Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the US: Analytic Framework and Review of the Literature by Ralph P. Insinga & Erik J. Dasbach & Elamin H. Elbasha [Downloadable!] 2005 Antiviral Agents for Influenza: A Comparison of Cost-Effectiveness Data by Larry D. Lynd & Ron Goeree & Bernie J. OBrien [Downloadable!] 2005 Economic Evaluations of Healthcare Programmes and Decision Making: The Influence of Economic Evaluations on Different Healthcare Decision-Making Levels by Marieke E. van Velden & Johan L. Severens & Annoesjka Novak [Downloadable!] 2005 Reporting Pharmacoeconomic Evaluations by C.I. Carswell & J.A. Paladino [Downloadable!] 2005 Pharmacological Management of Overactive Bladder: A Systematic and Critical Review of Published Economic Evaluations by Denis Getsios & Wissam El-Hadi & Ingrid Caro & J. Jaime Caro [Downloadable!] 2005 Measuring Health-Related Quality of Life in Older Patient Populations: A Review of Current Approaches by Anne Hickey & Maja Barker & Hannah McGee & Ciaran OBoyle [Downloadable!] 2005 Transparency in Economic Evaluations by Suzanne Hill [Downloadable!] 2005 Eplerenone: A Pharmacoeconomic Review of its Use in Patients with Post-Myocardial Infarction Heart Failure by Katherine F. Croom & Greg L. Plosker [Downloadable!] 2005 Financial Impact of Two Different Ways of Evaluating Early Virological Response to Peginterferon-alpha-2b Plus Ribavirin Therapy in Treatment-Naive Patients with Chronic Hepatitis C Virus Genotype 1 by Maria Buti & Miguel A. Casado & Leslie Fosbrook & Rafael Esteban [Downloadable!] 2005 Economic Analysis of On-Demand Maintenance Therapy with Proton Pump Inhibitors in Patients with Non-Erosive Reflux Disease by Dyfrig A. Hughes & Keith Bodger & Peter Bytzer & Dirk de Herdt & Dominique Dubois [Downloadable!] 2005 Using Policy Simulation to Predict Drug Plan Expenditure when Planning Reimbursement Changes by Colin R. Dormuth & Sean Burnett & Sebastian Schneeweiss [Downloadable!] 2005 The Cost Effectiveness of Orlistat in a 1-Year Weight-Management Programme for Treating Overweight and Obese Patients in Sweden: A Treatment Responder Approach by Peter Hertzman [Downloadable!] 2004 Explaining Sunday shop policies by Elbert Dijkgraaf & Raymond Gradus [Downloadable!] 2004 Trends in Australian Manufacturing by Productivity Commission [Downloadable!] 2004 Road Pricing, Traffic Congestion and Economic Welfare: A Note by Ingo_Böbel & Casimir_de_Rham [Downloadable!] 2004 Road Pricing, Traffic Congestion and Economic Welfare: A Note by Ingo_Böbel & Casimir_de_Rham [Downloadable!] 2004 The level of satisfaction with life: evidence gathered among women from Greater Montevideo by Maximo Rossi & Marisa Bucheli [Downloadable!] 2004 Evaluation of the Mutual Recognition Schemes by Productivity Commission [Downloadable!] 2004 Asymmetric Information and the Demand for Health Care - the Case of Double Moral Hazard by Udo Schneider [Downloadable!] 2004 The Estonian ICT Manufacturing and Software Industry: Current State and Future Outlook by Tarmo Kalvet [Downloadable!] 2004 Bureaucratic corruption and macroeconomic performance by Ingrid Ott [Downloadable!] 2004 Fashion Statement by Ted Temzelides [Downloadable!] 2004 When Promotions Induce Good Managers to Be Lazy by Antoine Renucci & Frédéric Loss [Downloadable!] 2004 When Promotions Induce Good Managers to Be Lazy by Antoine Renucci & Frédéric Loss [Downloadable!] 2004 Constitutional Rules by Francesco Giovannoni & Toke S. Aidt [Downloadable!] 2004 Overconfidence in Economic Contests by Munetomo Ando [Downloadable!] 2004 A Cost-Effectiveness Analysis of Fondaparinux Sodium Compared with Enoxaparin Sodium as Prophylaxis Against Venous Thromboembolism: Use in Patients Undergoing Major Orthopaedic Surgery by Sean D. Sullivan & Bruce L. Davidson & Susan R. Kahn & James E. Muntz & Gerry Oster & Gary Raskob [Downloadable!] 2004 The Burden of Migraine in Spain: Beyond Direct Costs by Xavier Badia & Sol Magaz & Laura Gutierrez & Jordi Galvan [Downloadable!] 2004 A Cost-Effectiveness Analysis of Docetaxel in the Second-Line Treatment of Non-Small Cell Lung Cancer by Jeremy Holmes & David Dunlop & Lindsay Hemmett & Peter Sharplin & Uday Bose [Downloadable!] 2004 Cost Effectiveness and Cost Utility of Adjuvant Interferon alpha in Cutaneous Melanoma: A Review by Ralph Crott [Downloadable!] 2004 Global Registries for Measuring Pharmacoeconomic and Quality-of-Life Outcomes: Focus on Design and Data Collection, Analysis and Interpretation by Lisa Kennedy & Ann-Marie Craig [Downloadable!] 2004 Outcome Measures for Pharmacoeconomics Education by Vittorio Maio & Jennifer H. Lofland [Downloadable!] 2004 Psychometric and Utility-Based Measures of Health Status of Asthmatic Patients with Different Disease Control Level by Agota Szende & Klas Svensson & Elisabeth Stahl & Agnes Meszaros & Gyula Y. Berta [Downloadable!] 2004 An Economic Evaluation of Fluvastatin used for the Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention in the UK by Paul A. Scuffham & Stephen Chaplin [Downloadable!] 2004 Growth Hormone Therapy and Quality of Life in Adults and Children by Deborah J. Radcliffe & Joseph S. Pliskin & J.B. Silvers & Leona Cuttler [Downloadable!] 2004 Pharmacogenomics and the Evolution of Healthcare: Is it Time for Cost-Effectiveness Analysis at the Individual Level? by Mohan V. Bala & Gary A. Zarkin [Downloadable!] 2004 The Role of Cost-Effectiveness Analysis in the Era of Pharmacogenomics by Christopher R. Flowers & David Veenstra [Downloadable!] 2004 Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C. The Authors' Reply by Sean D. Sullivan & Kavita Patel & Jesse Green [Downloadable!] 2004 Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive by Miguel Arguedas [Downloadable!] 2004 Drotrecogin Alfa (Activated): A Pharmacoeconomic Review of its Use in Severe Sepsis by James E. Frampton & Rachel H. Foster [Downloadable!] 2004 Management and Costs of Treating Lung Cancer Patients in a University Hospital by Konstantin J. Dedes & Thomas D. Szucs & Stephan Bodis & Markus Joerger & Adam Lowy & Erich W. Russi & Hans C. Steinert & Walter Weder & Rolf A. Stahel [Downloadable!] 2004 Economic Evaluations of Treatments for Systemic Fungal Infections: A Systematic Review of the Literature by Simon Dixon & Emma McKeen & Margaret Tabberer & Suzy Paisley [Downloadable!] 2004 Adherence to Guidelines for Community-Acquired Pneumonia: Does it Decrease Cost of Care? by Patricia D. Brown [Downloadable!] 2004 Repaglinide: A Pharmacoeconomic Review of its Use in Type 2 Diabetes Mellitus by Greg L. Plosker & David P. Figgitt [Downloadable!] 2004 Measuring Treatment Preferences and Willingness to Pay for Docetaxel in Advanced Ovarian Cancer by George Dranitsaris & Julia Elia-Pacitti & Wayne Cottrell [Downloadable!] 2004 Economic Implications of Treatment-Resistant Depression Among Employees by Paul Greenberg & Patricia K. Corey-Lisle & Howard Birnbaum & Maryna Marynchenko & Ami Claxton [Downloadable!] 2004 The Economic Burden of Allergic Rhinitis: A Critical Evaluation of the Literature by Shelby D. Reed & Todd A. Lee & Douglas C. McCrory [Downloadable!] 2004 Bernard J. O'Brien, BA, MSc, PhD by Deborah A. Freund [Downloadable!] 2004 Cost Effectiveness of Combination Therapy with Pioglitazone for Type 2 Diabetes Mellitus from a German Statutory Healthcare Perspective by Kurt Neeser & Georg Lubben & Uwe Siebert & Wendelin Schramm [Downloadable!] 2004 Cost Effectiveness of Representatives of Three Classes of Antidepressants Used in Major Depression in the UK by Alan Lenox-Smith & Pete Conway & Chris Knight [Downloadable!] 2004 Pharmacoeconomic Analysis of Amphotericin B Lipid Complex versus Liposomal Amphotericin B in the Treatment of Fungal Infections by Joseph L. Kuti & Srividya Kotapati & Peter Williams & Blair Capitano & Charles H. Nightingale & David P. Nicolau [Downloadable!] 2004 How Often Do Sensitivity Analyses for Economic Parameters Change Cost-Utility Analysis Conclusions? by Bruce R. Schackman & Heather Taffet Gold & Patricia W. Stone & Peter J. Neumann [Downloadable!] 2004 Longitudinal versus Cross-Sectional Methodology for Estimating the Economic Burden of Breast Cancer: A Pilot Study by C. Daniel Mullins & Junling Wang & Jesse L. Cooke & Lisa Blatt & Claudia R. Baquet [Downloadable!] 2004 Economic Impact of Respiratory Syncytial Virus-Related Illness in the US: An Analysis of National Databases by L. Clark Paramore & Vincent Ciuryla & Gabrielle Ciesla & Larry Liu [Downloadable!] 2004 The NICE Reference Case Requirement: More Pain for What, if Any, Gain? by Amiram Gafni & Stephen Birch [Downloadable!] 2004 The NICE Reference Case Requirement: Implications for Drug Manufacturers and Health Systems by Paul C. Langley [Downloadable!] 2004 Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C by Sean D. Sullivan & Antonio Craxi & Alfredo Alberti & Giovanni Giuliani & Claudio De Carli & Neil Wintfeld & Kavita K. Patel & Jesse Green [Downloadable!] 2004 Development and Validation of an Acceptability and Satisfaction Questionnaire for a Contraceptive Vaginal Ring, NuvaRing(R) by Annoesjka Novak & Christine de la Loge & Linda Abetz [Downloadable!] 2004 A by Manishi Prasad & Peter Wahlqvist & Rich Shikiar & Ya-Chen Tina Shih [Downloadable!] 2004 Aggressive Non-Hodgkin by Stephen M. Beard & Lucy Wall & Louise Gaffney & Fiona Sampson [Downloadable!] 2004 Psychometric Validation of the National Eye Institute Visual Function Questionnaire - 25 (NEI VFQ-25) French Version: In a Population of Patients Treated for Ocular Hypertension and Glaucoma by Jean-Phillipe Nordmann & Muriel Viala & Kate Sullivan & Benoit Arnould & Gilles Berdeaux [Downloadable!] 2004 Cost Effectiveness of Interventions for Lateral Epicondylitis: Results from a Randomised Controlled Trial in Primary Care by Ingeborg B.C. Korthals-de Bos & Nynke Smidt & Maurits W. van Tulder & Maureen P.M.H. Rutten-van Molken & Herman J. Ader & Danielle A.W.M. van der Windt & Willem J.J. Assendelft & Lex M. Bouter [Downloadable!] 2004 A Review of Health-Related Workplace Productivity Loss Instruments by Jennifer H. Lofland & Laura Pizzi & Kevin D. Frick [Downloadable!] 2004 Cost-of-Illness Studies in Diabetes Mellitus by Lorraine Ettaro & Thomas J. Songer & Ping Zhang & Michael M. Engelgau [Downloadable!] 2004 Education in Pharmacoeconomics: An International Multidisciplinary View by Karen L. Rascati & Michael F. Drummond & Lieven Annemans & Peter G. Davey [Downloadable!] 2004 Cost of Stress Urinary Incontinence: A Claims Data Analysis by Howard G. Birnbaum & Stephanie A. Leong & Emily F. Oster & Kraig Kinchen & Peter Sun [Downloadable!] 2004 Health Economic Evaluation of Non-Melanoma Skin Cancer and Actinic Keratosis by Mitchell K. Higashi & David L. Veenstra & Paul C. Langley [Downloadable!] 2004 The Generation Gap: Differences Between Children and Adults Pertinent to Economic Evaluations of Health Interventions by Ron Keren & Susmita Pati & Chris Feudtner [Downloadable!] 2004 Economic Evaluation of Varicella Vaccination Programmes: A Review of the Literature. The Authors' Reply by Nancy Thiry & Philippe Beutels & Pierre Van Damme & Eddy Van Doorslaer [Downloadable!] 2004 Economic Evaluation of Varicella Vaccination Programmes: A Review of the Literature by Thomas Hammerschmidt & Kurt Banz & Stefan Wagenpfeil & Albrecht Neiss & Peter Wutzler [Downloadable!] 2004 Infliximab: A Pharmacoeconomic Review of its Use in Rheumatoid Arthritis by Katherine A. Lyseng-Williamson & Rachel H. Foster [Downloadable!] 2004 Cost-Effective Strategies in the Prevention of Diabetic Nephropathy by Jonathan D. Rippin & Anthony H. Barnett & Stephen C. Bain [Downloadable!] 2004 Allocation of Resources Between Smoking Cessation Methods and Lovastatin Treatment of Hypercholesterolaemia: Based on Cost Effectiveness and the Social Welfare Function by Pedro Plans-Rubio [Downloadable!] 2004 A Multicentre Study of Patient Survival, Disability, Quality of Life and Cost of Care: Among Patients with AIDS in Northern Italy by Andrea Tramarin & Stefano Campostrini & Maarten J. Postma & Guido Calleri & Keith Tolley & Nicoletta Parise & Fausto de Lalla [Downloadable!] 2004 Why Did Drug Spending Increase During the 1990s?: A Decomposition Based on Swedish Data by Ulf-G. Gerdtham & Douglas Lundin [Downloadable!] 2004 Assessing the Value of Antipsychotics for Treating Schizophrenia: The Importance of Evaluating and Interpreting the Clinical Significance of Individual Service Costs by Sandra L. Tunis & Haya Ascher-Svanum & Michael Stensland & Bruce J. Kinon [Downloadable!] 2004 The Economic Implications of Non-Adherence after Renal Transplantation by Irina Cleemput & Katrien Kesteloot & Yves Vanrenterghem & Sabina De Geest [Downloadable!] 2004 The Effect of Cost Construction Based on Either DRG or ICD-9 Codes or Risk Group Stratification on the Resulting Cost-Effectiveness Ratios by Elinor C.G. Chumney & Andrea K. Biddle & Kit N. Simpson & Morris Weinberger & Kathryn M. Magruder & William N. Zelman [Downloadable!] 2004 Discrete Choice Experiment to Derive Willingness To Pay for Methyl Aminolevulinate Photodynamic Therapy Versus Simple Excision Surgery in Basal Cell Carcinoma by Adele Weston & Patrick FitzGerald [Downloadable!] 2004 Economic Costs to Business of the HIV/AIDS Epidemic by Gordon G. Liu & Jeff J. Guo & Scott R. Smith [Downloadable!] 2004 Valuing Prevention Through Economic Evaluation: Some Considerations Regarding the Choice of Discount Model for Health Effects with Focus on Infectious Diseases by Jasper M. Bos & Philippe Beutels & Lieven Annemans & Maarten J. Postma [Downloadable!] 2004 Acknowledgement by Adis International Limited [Downloadable!] 2004 Cost Effectiveness of Raloxifene in the Treatment of Osteoporosis in Sweden: An Economic Evaluation Based on the MORE Study by Fredrik Borgstrom & Olof Johnell & John A. Kanis & Anders Oden & David Sykes & Bengt Jonsson [Downloadable!] 2004 Relative Cost Effectiveness of Depo-Provera(R), Implanon(R), and Mirena(R) in Reversible Long-Term Hormonal Contraception in the UK by Susan J. Varney & Julian F. Guest [Downloadable!] 2004 Validation of the Work and Health Interview by Walter F. Stewart & Judith A. Ricci & Carol Leotta & Elsbeth Chee [Downloadable!] 2004 Measurement of Health-Related QOL in Diabetes Mellitus by Ken Watkins & Cathleen M. Connell [Downloadable!] 2004 Reconciliation of Economic Concerns and Health Policy: Illustration of an Equity Adjustment Procedure Using Proportional Shortfall by Elly A. Stolk & Gijs van Donselaar & Werner B.F. Brouwer & Jan J.V. Busschbach [Downloadable!] 2004 Etanercept: A Pharmacoeconomic Review of its Use in Rheumatoid Arthritis by Katherine A. Lyseng-Williamson & Greg L. Plosker [Downloadable!] 2004 Use and Cost of Antiretrovirals in France 1995-2000: An Analysis Based on the Medical Dossier on Human Immunodeficiency (release 2) Database by Yves A. Flori & Marc le Vaillant [Downloadable!] 2004 Cost-Effectiveness Analysis of Extended-Release Formulations of Oxybutynin and Tolterodine for the Management of Urge Incontinence by Dyfrig A. Hughes & Dominique Dubois [Downloadable!] 2004 Clinical and Economic Impact of Epoetins in Cancer Care by Monia Marchetti & Giovanni Barosi [Downloadable!] 2004 Economic Impact of Migraine and Other Episodic Headaches in France: Data from the GRIM2000 Study by Andre Pradalier & Jean-Paul Auray & Abdelkader El Hasnaoui & Kazem Alzahouri & Jean-Francois Dartigues & Gerard Duru & Patrick Henry & Michel Lanteri-Minet & Christian Lucas & Guy Chazot & Anne-Francois Gaudin [Downloadable!] 2004 Does Seropositivity for Helicobacter pylori Antibodies Increase Outpatient Costs for Gastric and Duodenal Ulcer or Inflammation? by Akira Babazono & Motonobu Miyazaki & Hiroshi Une & Eiji Yamamoto & Toshihide Tsuda & Yoshio Mino & Alan L. Hillman [Downloadable!] 2004 Cost Effectiveness of Ramipril in Patients at High Risk for Cardiovascular Events: Economic Evaluation of the HOPE (Heart Outcomes Prevention Evaluation) Study for Germany from the Statutory Health Insurance Perspective by Peter K. Schadlich & Josef G. Brecht & Badrudin Rangoonwala & Eduard Huppertz [Downloadable!] 2004 Cost Effectiveness of ACE Inhibitor Treatment for Patients with Type 1 Diabetes Mellitus by Frederick B. Dong & Stephen W. Sorensen & Diane L. Manninen & Theodore J. Thompson & Venkat Narayan & Carlyn E. Orians & Edward W. Gregg & Richard C. Eastman & Erik J. Dasbach & William H. Herman & Jeffrey M. Newman & Andrew S. Narva & David J. Ballard & Michael M. Engelgau [Downloadable!] 2004 Comparisons of Hypertension-Related Costs from Multinational Clinical Studies by C. Daniel Mullins & Mirko Sikirica & Viran Seneviratne & Jeonghoon Ahn & Kasem S. Akhras [Downloadable!] 2004 The Costs and Benefits of Community Thrombolysis for Acute Myocardial Infarction: A Decision-Analytic Model by Luke Vale & Harvey Steffens & Cam Donaldson [Downloadable!] 2004 Cost-Benefit Analysis of First-Generation Antihistamines in the Treatment of Allergic Rhinitis by Patrick W. Sullivan & Sheryl L. Follin & Michael B. Nichol [Downloadable!] 2004 Pharmacoeconomic Burden of Undertreating Hypertension by Luca Degli Esposti & Giorgia Valpiani [Downloadable!] 2004 Pharmacoeconomic Implications of New Therapies in Sepsis by Kelly A. Wood & Derek C. Angus [Downloadable!] 2004 Pharmacoeconomic Analysis of Bemiparin and Enoxaparin as Prophylaxis for Venous Thromboembolism in Total Knee Replacement Surgery by Jesus Honorato & Antonio Gomez-Outes & Antonio Navarro-Quilis & Javier Martinez-Gonzalez & Eduardo Rocha & Andre Planes [Downloadable!] 2004 Cost Effectiveness of Ibutilide With Prophylactic Magnesium in the Treatment of Atrial Fibrillation by Craig I. Coleman & James S. Kalus & C. Michael White & Anne P. Spencer & James P. Tsikouris & Jenny O. Chung & Kenneth W. Kenyon & Martin Ziska & Jeffrey Kluger & Prabashni Reddy [Downloadable!] 2004 A Decision Chart for Assessing and Improving the Transferability of Economic Evaluation Results Between Countries by Robert Welte & Talitha Feenstra & Hans Jager & Reiner Leidl [Downloadable!] 2004 Varicella Vaccination in Italy: An Economic Evaluation of Different Scenarios by Laurent Coudeville & Alain Brunot & Carlo Giaquinto & Carlo Lucioni & Benoit Dervaux [Downloadable!] 2004 Acute Rhinosinusitis: A Pharmacoeconomic Review of Antibacterial Use by Jean-Blaise Wasserfallen & Francoise Livio & Giorgio Zanetti [Downloadable!] 2004 Transferability of Economic Evaluation Results by Fernando Antonanzas [Downloadable!] 2004 Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma by Richard D. OConnor & Harold Nelson & Rohit Borker & Amanda Emmett & Priti Jhingran & Kathleen Rickard & Paul Dorinsky [Downloadable!] 2004 Economic Aspects of Severe Sepsis: A Review of Intensive Care Unit Costs, Cost of Illness and Cost Effectiveness of Therapy by Hilmar Burchardi & Heinz Schneider [Downloadable!] 2004 Assessing the Use of Retrospective Databases in Conducting Economic Evaluations of Drugs: The Case of Asthma by Fredrik Berggren [Downloadable!] 2004 Incorporation of Statistical Uncertainty in Health Economic Modelling Studies Using Second-Order Monte Carlo Simulations by Mark J.C. Nuijten [Downloadable!] 2004 Resource Use and Cost of Care for Patients Hospitalised with Community Acquired Pneumonia: Impact of Adherence to Infectious Diseases Society of America Guidelines by Joanne J. Orrick & Richard Segal & Th 
